Metabolism of exogenous arachidonic acid by polymorphonuclear leukocytes from psoriatic patients
- PMID: 2069415
- DOI: 10.1007/BF00371612
Metabolism of exogenous arachidonic acid by polymorphonuclear leukocytes from psoriatic patients
Abstract
We evaluated the metabolism of exogenous arachidonic acid in polymorphonuclear leukocytes from psoriatic patients in comparison with those from normal subjects. The leukocytes were incubated with 10 microM labelled arachidonic acid and 5 microM A23187 for varying periods of time. We evaluated all the compounds derived from the 5-lipoxygenase activity, including the products of non-enzymatic transformation of leukotriene A4 and w-oxidized leukotriene B4. In the experimental conditions used, there was no significant difference in the formation of any compound at any time of incubation. These results indicate that there is no intrinsic alteration either in 5-lipoxygenase activity or in w-oxidation ability of circulating polymorphonuclear leukocytes in psoriatic patients.
Similar articles
-
Arachidonic acid metabolism by polymorphonuclear leukocytes in psoriasis.Br J Dermatol. 1986 Jan;114(1):57-64. doi: 10.1111/j.1365-2133.1986.tb02779.x. Br J Dermatol. 1986. PMID: 3002416
-
Epidermal cell-polymorphonuclear leukocyte cooperation in the formation of leukotriene B4 by transcellular biosynthesis.J Invest Dermatol. 1992 Mar;98(3):333-9. doi: 10.1111/1523-1747.ep12499800. J Invest Dermatol. 1992. PMID: 1312107
-
The metabolism of leukotriene B4 by peripheral blood polymorphonuclear leukocytes in psoriasis.Prostaglandins. 1987 Jun;33(6):807-18. doi: 10.1016/0090-6980(87)90109-2. Prostaglandins. 1987. PMID: 2823314
-
Lipoxin formation in human nasal polyps and bronchial tissue.FEBS Lett. 1990 Oct 15;272(1-2):25-8. doi: 10.1016/0014-5793(90)80440-t. FEBS Lett. 1990. PMID: 2172016
-
Complement-mediated arachidonate metabolism.Prog Biochem Pharmacol. 1985;20:120-31. Prog Biochem Pharmacol. 1985. PMID: 2986155 Review.
Cited by
-
Tumour cell lines HT-29 and FaDu produce proinflammatory cytokines and activate neutrophils in vitro: possible applications for neutrophil-based antitumour treatment.Mediators Inflamm. 2009;2009:817498. doi: 10.1155/2009/817498. Epub 2010 Feb 11. Mediators Inflamm. 2009. PMID: 20169105 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical